Scilla Latini

856 total citations
13 papers, 707 citations indexed

About

Scilla Latini is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Scilla Latini has authored 13 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Scilla Latini's work include Cancer therapeutics and mechanisms (4 papers), Vanadium and Halogenation Chemistry (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Scilla Latini is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Vanadium and Halogenation Chemistry (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Scilla Latini collaborates with scholars based in Denmark and Sweden. Scilla Latini's co-authors include Lise Binderup, Ernst Binderup, Kerrin Hansen, Claus Bretting, Martin J. Calverley, E. Bramm, Fredrik Björkling, Rolf Larsson, Torsten Skov and Sumeer Dhar and has published in prestigious journals such as International Journal of Cancer, Biochemical Pharmacology and Biochimica et Biophysica Acta (BBA) - Bioenergetics.

In The Last Decade

Scilla Latini

13 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scilla Latini Denmark 10 267 258 153 140 131 13 707
Madhavi Sekharam United States 11 452 1.7× 112 0.4× 328 2.1× 32 0.2× 35 0.3× 14 789
Olivia Aranha United States 13 398 1.5× 83 0.3× 213 1.4× 129 0.9× 38 0.3× 34 676
Filippa Pettersson Canada 18 654 2.4× 58 0.2× 220 1.4× 49 0.3× 104 0.8× 26 884
Long Shan Li United States 13 480 1.8× 177 0.7× 178 1.2× 112 0.8× 38 0.3× 16 709
Manuela Gridling Austria 13 672 2.5× 45 0.2× 269 1.8× 126 0.9× 35 0.3× 17 1.0k
T.T. Kwok Hong Kong 18 541 2.0× 125 0.5× 227 1.5× 24 0.2× 34 0.3× 24 974
Dawn R. Church United States 14 421 1.6× 49 0.2× 128 0.8× 108 0.8× 50 0.4× 23 675
Virginie Poindessous France 17 484 1.8× 61 0.2× 282 1.8× 60 0.4× 19 0.1× 32 837
David Ordaz‐Rosado Mexico 13 252 0.9× 130 0.5× 107 0.7× 47 0.3× 78 0.6× 34 512

Countries citing papers authored by Scilla Latini

Since Specialization
Citations

This map shows the geographic impact of Scilla Latini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scilla Latini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scilla Latini more than expected).

Fields of papers citing papers by Scilla Latini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scilla Latini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scilla Latini. The network helps show where Scilla Latini may publish in the future.

Co-authorship network of co-authors of Scilla Latini

This figure shows the co-authorship network connecting the top 25 collaborators of Scilla Latini. A scholar is included among the top collaborators of Scilla Latini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scilla Latini. Scilla Latini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Binderup, Ernst, et al.. (2005). EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828. Bioorganic & Medicinal Chemistry Letters. 15(10). 2491–2494. 44 indexed citations
2.
Latini, Scilla, Pernille Holm, Rolf Larsson, et al.. (2004). Anticancer agent CHS 828 suppresses nuclear factor‐κB activity in cancer cells through downregulation of IKK activity. International Journal of Cancer. 111(2). 198–205. 39 indexed citations
3.
Lindhagen, Elin, et al.. (2004). Pharmacodynamic differences between species exemplified by the novel anticancer agent CHS 828. Drug Development Research. 61(4). 218–226. 4 indexed citations
4.
Sørensen, Morten Dahl, et al.. (2003). Cyclic phosphinamides and phosphonamides, novel series of potent matrix metalloproteinase inhibitors with antitumour activity. Bioorganic & Medicinal Chemistry. 11(24). 5461–5484. 74 indexed citations
5.
Junker, Nanna, Scilla Latini, Lone N. Petersen, & Paul E.G. Kristjansen. (2003). Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.. PubMed. 10(3). 609–16. 33 indexed citations
6.
Jönsson, E., Scilla Latini, Sumeer Dhar, et al.. (1999). CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.. PubMed. 59(22). 5751–7. 97 indexed citations
7.
Hansen, Christina Mørk, et al.. (1998). Down-regulation of Laminin-Binding Integrins by 1α,25=Dihydroxyvitamin D3in Human Melanoma Cells in Vitro. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 5(2). 109–120. 22 indexed citations
8.
Petersen, Hans, et al.. (1998). ChemInform Abstract: Novel Cyanoguanidines with Potent Oral Antitumor Activity.. ChemInform. 29(17). 5 indexed citations
9.
Björkling, Fredrik, et al.. (1997). Novel cyanoguanidines with potent oral antitumour activity. Bioorganic & Medicinal Chemistry Letters. 7(24). 3095–3100. 47 indexed citations
10.
Kissmeyer, Anne‐Marie, Ida Stenfeldt Mathiasen, Scilla Latini, & Lise Binderup. (1995). Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine. 3(4). 263–266. 43 indexed citations
11.
Binderup, Lise, Scilla Latini, Ernst Binderup, et al.. (1991). 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochemical Pharmacology. 42(8). 1569–1575. 274 indexed citations
12.
Klarlund, Jes K., Scilla Latini, & Jes Forchhammer. (1988). Numerous proteins phosphorylated on tyrosine and enhanced tyrosine kinase activities in vanadate-treated NIH 3T3 fibroblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 971(1). 112–120. 23 indexed citations
13.
Klarlund, Jes K., Scilla Latini, & Jes Forchhammer. (1988). Numerous proteins phosphorylated on tyrosine and enhanced tyrosine kinase activities in vanadate-treated NIH 3T3 fibroblasts. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 971(1). 112–120. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madhavi Sekharam Breakdown of academic impact, for papers by Olivia Aranha Breakdown of academic impact, for papers by Filippa Pettersson Breakdown of academic impact, for papers by Long Shan Li Breakdown of academic impact, for papers by Manuela Gridling Breakdown of academic impact, for papers by T.T. Kwok Breakdown of academic impact, for papers by Dawn R. Church Breakdown of academic impact, for papers by Virginie Poindessous Breakdown of academic impact, for papers by David Ordaz‐Rosado
Rankless by CCL
2026